Table:
begin	end	state
1	19	cytoplasmic
20	41	transmembrane
42	46	non-cytoplasmic
47	66	transmembrane
67	85	cytoplasmic
86	106	transmembrane
107	125	non-cytoplasmic
126	145	transmembrane
146	153	cytoplasmic
154	176	transmembrane
177	195	non-cytoplasmic
196	220	transmembrane
221	240	cytoplasmic
241	261	transmembrane
262	291	non-cytoplasmic
292	311	transmembrane
312	342	cytoplasmic
343	364	transmembrane
365	369	non-cytoplasmic
370	389	transmembrane
390	408	cytoplasmic
409	431	transmembrane
432	436	non-cytoplasmic
437	455	transmembrane
456	473	cytoplasmic

Input:
>AO353_18555
MSGQNSHSGTLQRGLKNRHIQLIALGGAIGTGLFLGSAGVLKSAGPSMILGYAICGFIAF
MIMRQLGEMIVEEPVAGSFSHFAHKYWGGFAGFLSGWNCWILYILVGMSELTAVGKYVHY
WWPDVPTWASAAVFFVMINAINLANVKVFGEAEFWFAIIKVVAIVGMIALGSYLLVSGHG
GPQASVSNLWEHGGFFPNGVSGLVMAMAIIMFSFGGLEMLGFTAAEADKPKTVIPKAINQ
VIYRILIFYIGALVVLLSLTPWDSLLVSLNASGDAYSGSPFVQVFSMLGSKTAAHILNFV
VLTAALSVYNSGTYCNSRMLLGMAEQGDAPKGLAKIDKRGVPVRSILASAAVTFVAVVMN
YLIPQHALELLMSLVVATLVINWAMISYSHFKFRQHMNRTKQTPLFKALWYPYGNYICLA
FVAFILCIMLMIPGIQISVYAIPVWVLFMWVCYNIKNKRSAQHALNAAASAVK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server